Assuming the data was collected on time from the trials, how hard can it be to do the topline analysis? It can only be the second trial where there could be any kind of rush / delay. I'd like to think that GW are bullying whoever is doing the analysis to work round the clock to deliver. Has anyone spoken to the company to ask what is going on? I can't believe GW would really be saying "ok, just email us when you feel like it." I would have thought they would be saying "you've got all the data now, this will take x days to process, we want the results on such and such a day." No?
GW Pharm stock quotes
GW Pharm stock charts
Follow this thread
